So far for 2017 the IPO analysts and investors are happy with the start. Keane Group (FRAC  ) was officially marked as the year's first IPO they raised $508 million and finished its debut up 14%. Analysts are also excited at the promise of the energy sector. Remember that last year we didn't see any real activity from the oil space until around September.

There were also 10 new companies that threw their name into the IPO hat last week looking to raise money. If they are able to launch this week then this would be more IPO's than the entire first quarter of 2016. We have 8 that are officially scheduled this week which is a tie for the most active week last year.

Jagged Peak Energy (JAG  ) is looking for $650 million by offering 38 million shares at a range of $16-18. This will be the most focused on IP this week as analysts continue to look for more promising signs in the energy space. It is also the largest of the week.

Jeld-Wen Holdings (JELD  ) will be looking for $550 million by offering 25 million shares at a range of $21-23. They are a global manufacturer of doors and windows.

REV Group (REVG  ) will offer 12.5 million shares at a range of $19-21 and is hoping to bring in $250 million to grow its emergency vehicle manufacturing company.

AppDynamics (APPD  ) will be the first venture capital backed company to go public this year. The company will offer 12 million shares at a range of $10-12 to try and raise $132 million.

ObsEva (OBSV  ) will be looking to continue to fund its clinical-stage biotech therapies for woman's health by raising $97 million. The company will sell off 6.4 million shares at $14-16.

Jounce Therapeutics (JNCE  ) is an "early-stage biotech developing T cell immuno-oncology therapies with Celgene." The company hopes to raise $75 million by offering 5.3 million shares at a range of $13-15.

AnaptysBio (ANAB  ) is an "early-stage biotech developing antibodies for severe peanut allergy and asthma." They are looking to raise $60 million with a small offering of 4 million shares at a range of $14-16.

Visterra (VIST  ) is the smallest offering of the week with 3.8 million shares at $12-14. The company hopes to raise $50 million to continue to develop targeted vaccines for influenza and other infectious diseases.